The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Meta‐analysis of second‐trimester markers for trisomy 21
Open accessAbstract
Objective: To summarize by meta‐analysis the accumulated data on the screening performance of second‐trimester sonographic markers for fetal trisomy 21. Methods: We conducted a literature search to identify studies between 1995 and September 2012 that provided data on the incidence of sonographic markers in trisomy 21 and euploid fetuses at 14–24 weeks' gestation. Weighted independent estimates of detection rate, false‐positive rate and positive and negative likelihood ratios (LR) of markers were calculated. Results: A total of 48 studies was included in the analysis. The pooled estimates of positive and negative LR were, respectively: 5.83 (95% CI, 5.02–6.77) and 0.80 (95% CI, 0.75–0.86) for intracardiac echogenic focus; 27.52 (95% CI, 13.61–55.68) and 0.94 (95% CI, 0.91–0.98) for ventriculomegaly; 23.30 (95% CI, 14.35–37.83) and 0.80 (95% CI, 0.74–0.85) for increased nuchal fold; 11.44 (95% CI, 9.05–14.47) and 0.90 (95% CI, 0.86–0.94) for hyperechogenic bowel; 7.63 (95% CI, 6.11–9.51) and 0.92 (95% CI, 0.89–0.96) for mild hydronephrosis; 3.72 (95% CI, 2.79–4.97) and 0.80 (95% CI, 0.73–0.88) for short femur; 4.81 (95% CI, 3.49–6.62) and 0.74 (95% CI, 0.63–0.88) for short humerus; 21.48 (95% CI, 11.48–40.19) and 0.71 (95% CI, 0.57–0.88) for aberrant right subclavian artery (ARSA); and 23.27 (95% CI, 14.23–38.06) and 0.46 (95% CI, 0.36–0.58) for absent or hypoplastic nasal bone. The combined negative LR, obtained by multiplying the values of individual markers, was 0.13 (95% CI, 0.05–0.29) when short femur but not short humerus was included and 0.12 (95% CI, 0.06–0.29) when short humerus but not short femur was included. Conclusion: The presence of sonographic markers increases, and absence of such markers decreases, the risk for trisomy 21. In the case of most isolated markers there is only a small effect on modifying the pre‐test odds for trisomy 21, but with ventriculomegaly, nuchal fold thickness and ARSA there is a 3–4‐fold increase in risk and with hypoplastic nasal bone a 6–7‐fold increase. Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis
Petitti, D. B. (1999) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195133646.001.0001 · Cited by 925
Second-Trimester Ultrasound to Detect Fetuses With Down Syndrome: A Meta-analysis
Smith-Bindman, R., Hosmer, W., Feldstein, V. A., Deeks, J. J., & Goldberg, J. D. (2001) · JAMA · doi:10.1001/jama.285.8.1044 · Cited by 306
Nyberg, D. A., Souter, V. L., El-Bastawissi, A., Young, S., Luthhardt, F., & Luthy, D. A. (2001) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2001.20.10.1053 · Cited by 284
Screening for chromosomal defects
Nicolaides, K. H. (2003) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.128 · Cited by 225
Self-citationThe Genetic Sonogram: A Method of Risk Assessment for Down Syndrome in the Second Trimester
Bromley, B., Lieberman, E., Shipp, T. D., & Benacerraf, B. R. (2002) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2002.21.10.1087 · Cited by 213
Nasal bone hypoplasia in trisomy 21 at 15–22 weeks' gestation
Cicero, S., Sonek, J. D., Mckenna, D. S., Croom, C. S., Johnson, L., & Nicolaides, K. H. (2003) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19 · Cited by 199
Self-citationBromley, B., Lieberman, E., SHIPP, T. D., & Benacerraf, B. R. (2002) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2002.21.12.1387 · Cited by 146
Role of Second-Trimester Genetic Sonography After Down Syndrome Screening
Aagaard-Tillery, K. M., Malone, F. D., Nyberg, D. A., Porter, T. F., Cuckle, H., Fuchs, K. M., SULLIVAN, L. M., Comstock, C. H., Saade, G. R., Eddleman, K. A., et al. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181c15064 · Cited by 119
Bunduki, V., Ruano, R., Miguelez, J., Yoshizaki, C. T., Kahhale, S., & Zugaib, M. (2003) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.31 · Cited by 116
Vintzileos, A. M., Campbell, W. A., Rodis, J. F., Guzman, E., Smulian, J. C., & Knuppel, R. A. (1996) · Obstetrics and Gynecology · doi:10.1016/0029-7844(96)00053-1 · Cited by 109
Smith‐Bindman, R., Chu, P., & Goldberg, J. D. (2007) · Prenatal Diagnosis · doi:10.1002/pd.1725 · Cited by 97
Revisiting the risk for aneuploidy in fetuses with isolated pyelectasis
Carbone, J. F., Tuuli, M. G., Dicke, J. M., Macones, G. A., & Odibo, A. O. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2749 · Cited by 97
Borenstein, M., Minekawa, R., Zidere, V., Nicolaides, K. H., & Allan, L. D. (2010) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.7683 · Cited by 88
Self-citationDiagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis*1
Sotiriadis, A. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00168-6 · Cited by 81
Fetal aberrant right subclavian artery in normal and Down syndrome fetuses
Zalel, Y., Achiron, R., Yagel, S., & Kivilevitch, Z. (2007) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.5230 · Cited by 77
Isolated fetal pyelectasis and chromosomal abnormalities
Coco, C., & Jeanty, P. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.02.074 · Cited by 67
Prenasal thickness in trisomy‐21 fetuses at 16–24 weeks of gestation
Persico, N., Borenstein, M., Molina, F. S., Azumendi, G., & Nicolaides, K. H. (2008) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.5404 · Cited by 61
Self-citationNatural history of trisomy 21 fetuses with increased nuchal translucency thickness
Pandya, P. P., Snijders, R. J. M., Johnson, S. W., & Nicolaides, K. H. (1995) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1995.05060381.x · Cited by 56
Self-citationCoco, C., Jeanty, P., & Jeanty, C. (2004) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2004.23.4.489 · Cited by 49
Ultrasonographic measurement of fetal nasal bone in a low‐risk population at 19–22 gestational weeks
Gámez, F., Ferreiro, P., & Salmeán, J. M. (2003) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.929 · Cited by 42
Relationship between nuchal translucency at 11–14 weeks and nuchal fold at 20–24 weeks of gestation
Salomon, L. J., Bernard, J. P., Taupin, P., Bénard, C., & Ville, Y. G. (2001) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.0960-7692.2001.00582.x · Cited by 31
Ultrasound Findings After Screening for Down Syndrome Using the Integrated Test
Weisz, B., Pandya, P. P., David, A. L., Huttly, W. J., Jones, P., & Rodeck, C. H. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000260234.20190.6e · Cited by 29
Maymon, R., Zimerman, A. L., Weinraub, Z., Herman, A., & Cuckle, H. (2008) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.5307 · Cited by 28
Schlüter, P. J., & Pritchard, G. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.036 · Cited by 26
Miguelez, J., Brizot, M. D. L., Liao, A. W., de Carvalho, M. H. B., & Zugaib, M. (2011) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.9024 · Cited by 22
Early genetic sonogram for down syndrome detection
Bahado-Singh, R. O., Mendilcioğlu, İ., Rowther, M., Choi, S., Öz, U., Yousefi, N. F., & Mahoney, M. J. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126975 · Cited by 18
Cited by
Melamed, N., Baschat, A., Yinon, Y., Athanasiadis, A., Mecacci, F., Figueras, F., Berghella, V., Nazareth, A., Tahlak, M., McIntyre, H. D., et al. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13522 · Cited by 570
Self-citation“Down syndrome: an insight of the disease”
Asim, A., Kumar, A., Muthuswamy, S., Jain, S., & Agarwal, S. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0138-y · Cited by 371
Benn, P., Borrell, A., Chiu, R. W. K., Cuckle, H., Dugoff, L., Faas, B., Gross, S., Huang, T., Johnson, J., Maymon, R., et al. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4608 · Cited by 292
Practice Bulletin No. 175: Ultrasound in Pregnancy
(2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001815 · Cited by 282
Practice Bulletin No. 163: Screening for Fetal Aneuploidy
(2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001406 · Cited by 273
Metadata
- Authors
- Agathokleous, M., Chaveeva, P., Poon, L. C. Y., Kosinski, P., & Nicolaides, K. H.
- Venue
- Ultrasound in Obstetrics & Gynecology
- Publisher
- Wiley
- Published
- 2013-01-24
- Volume
- 41
- Issue
- 3
- Pages
- 247-261
- ISSN
- 0960-7692 (ISSN-L)
- 1469-0705
- OpenAlex
- W1599865413
- Cited by
- 329
- References
- 31
- FWCI
- 16.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.